Insights into EGFR Mutations and Oncogenic KRAS Mutations in Non-Small-Cell Lung Cancer

被引：0
|
作者：
Rosell, Rafael [1 ,2 ]
Aguilar-Hernandez, Andres [2 ]
Gonzalez-Cao, Maria [2 ]
机构：
[1] Germans Trias & Pujol Res Inst, Badalona 08916, Spain
[2] Hosp Quiron Dexeus, IOR, Barcelona 08028, Spain
来源：
CANCERS | 2023年 / 15卷 / 09期
关键词：
KINASE;
D O I：
10.3390/cancers15092519
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [21] BRAF Mutations in Non-Small-Cell Lung Cancer
    Smit, Egbert
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (11) : 1594 - 1595
  • [22] Frequency of EGFR Mutations in Greek Non-Small-Cell Lung Cancer (NSCLC) Patients
    Nasioulas, G.
    Efstathiadou, C.
    Murray, S.
    Dahabreh, I.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S635 - S635
  • [23] Rare mutations in non-small-cell lung cancer
    D'Arcangelo, Manolo
    D'Incecco, Armida
    Cappuzzo, Federico
    FUTURE ONCOLOGY, 2013, 9 (05) : 699 - 711
  • [24] Frequency of EGFR mutations in Greek non-small-cell lung cancer (NSCLC) patients
    Murray, Samuel
    Papadopoulou, Eirini
    Nasioulas, George
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [25] Searching for a chemoimmunotherapy signal in patients with non-small-cell lung cancer and EGFR mutations
    Pacheco, Jose M.
    Camidge, D. Ross
    LANCET RESPIRATORY MEDICINE, 2019, 7 (05): : 366 - 367
  • [26] Mutations in main candidate genes (egfr, kras, braf) among patients with non-small-cell lung cancer from sardinia
    Colombino, M.
    Paliogiannis, P.
    Defraia, E.
    Porcu, G.
    Pazzola, A.
    Cordero, L.
    Palomba, G.
    Sini, M. C.
    Manca, A.
    Carta, A.
    Saba, E. M.
    Scotto, T.
    Sarobba, M. G.
    Capelli, F.
    Ortu, S.
    Baldino, G.
    Sedda, T.
    Pirina, P.
    Budroni, M.
    Cossu, A.
    Palmieri, G.
    ANNALS OF ONCOLOGY, 2015, 26 : 84 - 84
  • [27] Impact of EGFR mutations and KRAS amino acid substitution on the response to radiotherapy for brain metastasis of non-small-cell lung cancer
    Renaud, Stephane
    Schaeffer, Mickael
    Voegeli, Anne-Claire
    Legrain, Michele
    Guerin, Eric
    Meyer, Nicolas
    Mennecier, Bertrand
    Quoix, Elisabeth
    Falcoz, Pierre-Emmanuel
    Guenot, Dominique
    Massard, Gilbert
    Noel, Georges
    Beau-Faller, Michele
    FUTURE ONCOLOGY, 2016, 12 (01) : 59 - 70
  • [28] EGFR and KRAS mutations, and ALK fusions: current developments and personalized therapies for patients with advanced non-small-cell lung cancer
    de Mello, Ramon Andrade
    Madureira, Pedro
    Carvalho, Liliana S.
    Araujo, Antonio
    O'Brien, Mary
    Popat, Sanjay
    PHARMACOGENOMICS, 2013, 14 (14) : 1765 - 1777
  • [29] Oncogenic driver mutations in patients with non-small-cell lung cancer at various clinical stages
    Zhou, J. X.
    Yang, H.
    Deng, Q.
    Gu, X.
    He, P.
    Lin, Y.
    Zhao, M.
    Jiang, J.
    Chen, H.
    Lin, Y.
    Yin, W.
    Mo, L.
    He, J.
    ANNALS OF ONCOLOGY, 2013, 24 (05) : 1319 - 1325
  • [30] KRAS and BRAF Double Mutations and Functional Classes of BRAF Mutations in Non-small-cell Lung Cancers
    Bourhis, Amelie
    Remoue, Annabelle
    Uguen, Arnaud
    CLINICAL LUNG CANCER, 2020, 21 (04) : E240 - E242
12345